Navigation Links
Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimer's Disease
Date:8/6/2012

NEW BRUNSWICK, N.J., Aug. 6, 2012 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced that phase 3 clinical development of bapineuzumab intravenous (IV) in mild-to-moderate Alzheimer's disease is being discontinued. 

Janssen Alzheimer Immunotherapy (Janssen AI), a subsidiary of Johnson & Johnson, is a partner with Pfizer in the Alzheimer's Immunotherapy Program (AIP). The Joint Steering Committee for the AIP has decided to discontinue the development of bapineuzumab IV in mild-to-moderate Alzheimer's disease based on the co-primary clinical endpoints not being met in the Janssen AI-led Studies 301 and 302. Pfizer has issued separate news releases on the top line results of both of these Janssen AI-led studies.

"While we are disappointed in the results of the two bapineuzumab IV studies, particularly in light of the urgent need for new advancements in Alzheimer's disease, we believe that targeting and clearing beta amyloid remains a promising path to potential clinical benefits for people suffering from this disease," said Husseini K. Manji, M.D., Global Therapeutic Area Head for Neuroscience, Janssen Research & Development, LLC. "Janssen remains strongly committed to tackling the enormous unmet medical needs in Alzheimer's disease. We believe the trial results will provide a rich data set that will advance our understanding of this complex disease and inform future research in this field. Studies with other compounds in earlier stages of development in the AIP portfolio are continuing and future development strategies will be discussed jointly by the alliance partners."

The Company expects to record an after-tax, non-cash special item related to in-process research and development consisting of a net charge to earnings of between $300 and $400 million in the third quarter of 2012 related to the discontinuation of the ph
'/>"/>

SOURCE Johnson & Johnson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
2. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
3. N.J. Woman Sues Johnson & Johnsons Ethicon Unit Over Vaginal Mesh Injuries, Says The Lanier Law Firm
4. Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results
5. GHX CEO Bruce Johnson Recognized as Ernst & Young Rocky Mountain Region Entrepreneur of the Year 2012
6. Johnson & Johnson Provides Notice Of Proposed Settlement Of Shareholder Derivative Actions, Final Settlement Hearing, And Right To Appear
7. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
8. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
9. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
10. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
11. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... -- Zacks.com announces the list of stocks featured in the Analyst ... latest news and events impacting stocks and the financial markets. ... HPQ - Free Report ), IBM (NYSE: IBM - ... Free Report ), GlaxoSmithKline plc (NYSE: GSK - Free ... Free Report ). Today, Zacks is promoting its ...
(Date:8/21/2014)... 2014  Armada Health Care (Armada), the nation,s ... pleased to announce an agreement with Aurora Health ... innovative specialty pharmacy patient program offerings. The new ... services to specialty patients via Armada,s proprietary ReachRx ... will use the OTM platform as its case ...
(Date:8/21/2014)... - Bedrocan Cannabis Corp., previously Bedrocan Canada Inc. ("Bedrocan") ... of Directors, enhancing executive oversight and strengthening the ... licensed producer of medicinal cannabis in ... experience in producing and supplying government-regulated pharmaceutical-grade cannabis ... As previously announced in a press ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3
... of stent timing and type, prasugrel bests clopidogrel, ... shown to block,platelet activity in patients with acute ... cut by more than half the risk of,thrombosis, ... a new,analysis of data from the Trial to ...
... With drug-eluting stents, is the ,crush, or ,culotte, technique ... performed for an,arterial narrowing at the branchpoint of two ... be challenging to achieve full coverage of,both vessels without ... study,will provide interventional cardiologists with new information on which ...
Cached Medicine Technology:TRITON-TIMI 38 Stent Analysis Favors Prasugrel 2TRITON-TIMI 38 Stent Analysis Favors Prasugrel 3Stenting Techniques Vie in Branchpoint Lesions 2
(Date:8/21/2014)... Improv performers from Fun House Theatre ... at Silverado Turtle Creek memory care community in Dallas. ... ranging from ages 10 to 16, delivers a groundbreaking ... set. The troupe's philosophy is that improv is based ... to touch audiences regardless of their circumstance — including ...
(Date:8/21/2014)... Grove, California (PRWEB) August 21, 2014 ... the initial plans for entertainment and programming for its ... Event.” On Sunday, October 12, 2014, from 11 a.m. ... be closed to all cars and the downtown will ... and activities, curated by Community Arts Resources (CARS), for ...
(Date:8/21/2014)... -- Among seniors, dimming vision may be tied to ... than 2,500 people, aged 65 to 84, who were assessed ... and eight years later. Vision loss over time was ... during the study period, the researchers reported. Although the ... Christ of Purdue University in West Lafayette, Ind., offered up ...
(Date:8/21/2014)... Rockville, MD (PRWEB) August 21, 2014 ... Pediatrics reported a 63% increase in disability associated with ... along with a more than 15% increase in disability ... of early intervention for rising numbers of children who ... Speech-Language-Hearing Association (ASHA). , On a broader ...
(Date:8/21/2014)... Researchers in the United Kingdom have demonstrated that advanced ... diagnose a number of rare diseases marked by childhood ... today in Ophthalmology , the journal of the ... doctors were able to tailor care specifically to a ... and money spent on diagnosis and enabling earlier treatment ...
Breaking Medicine News(10 mins):Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3Health News:New DNA test for diagnosing diseases linked to childhood blindness 2
... Organization (WHO) estimates that 20.1 million individuals were infected ... across 9 world regions in 2005. According to findings ... a journal published by Wiley-Blackwell on behalf of the ... were 3.4 million symptomatic cases, 70,000 deaths, and 3,000 ...
... lives can greatly affect his or her risk for asthma. ... neighborhood differences in rates of childhood asthma may be explained ... heating oil. Results appear online in the Journal of ... City, where the study was conducted, asthma among school-age children ...
... of autism spectrum disorder (ASD) has been steadily climbing from ... 1,000 children in 2006, according to the Centers for Disease ... research with young kids can lead to important insights in ... in the Journal of Visualized Experiments , researchers demonstrate ...
... HealthDay Reporter , MONDAY, March 26 (HealthDay News) ... antibody" lowered LDL cholesterol levels in patients with high ... new treatment could help lower levels of "bad" cholesterol ... to the commonly prescribed cholesterol-lowering drugs known as statins. ...
... Mary, University of London has uncovered the mechanism which causes ... fight against one of the UK,s biggest killers*. The ... today (26 March), investigated the role of the notorious cancer ... Mary, University of London, said the team found that the ...
... left hand would shake when he tried to use it, making ... a check, or making a sandwich challenging. The tremor eventually became ... sought care and learned that his tremor was a symptom of ... "I was familiar with Parkinson,s because my father had it ...
Cached Medicine News:Health News:Over 20 million individuals infected with hepatitis E in Asia and Africa 2Health News:Air pollution from trucks and low-quality heating oil may explain childhood asthma hot spots 2Health News:Research into children with autism published in JoVE 2Health News:New Injection Might Lower Tough-to-Treat Cholesterol 2Health News:New Injection Might Lower Tough-to-Treat Cholesterol 3Health News:Research gives hope to detecting cancer in early stages 2Health News:Essential tremor patient regains independence following surgery 2Health News:Essential tremor patient regains independence following surgery 3Health News:Essential tremor patient regains independence following surgery 4
High intensity halogen lamp with built-in, switchable spare. Optical light concentrator to optimize existing light energy....
... AlphaCor is a biocompatible, flexible, one-piece artificial ... or diseased native cornea., ,The World Health ... more than 10 million people worldwide, however ... year. This shortfall is due to a ...
PDA-version of the complete ICD-9 diagnosis codes....
PDA formatted guide containing outlines and detailed information on the diagnosis and treatment of HIV infection and AIDS....
Medicine Products: